Key Players
Competitive Landscape
Four business models shape competition in eating-disorder recovery nutrition: global medical-nutrition groups, oral-nutrition specialists, clinical-food manufacturers, and region-focused high-nutrition brands. Relevant products need clinician-supervised nutritional rehabilitation or a closely adjacent medical-nutrition route, which excludes ordinary wellness shakes from this competitive set.
During 2025, investment moved toward broader format choice and wider access without abandoning clinical credibility. Kate Farms launched its High Protein Nutrition Shake in July 2025, extending plant-based ready-to-drink development. Nestlé Health Science added university collaborations in November 2025 for nutrition and health research. Competition now turns on format choice, medical-use evidence, and continuity between clinical and home channels.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| AYMES Nutrition introduced ActaSolve Shake Compact Warm Ginger in April 2026 while keeping existing PIP codes. | Recovery programs need compact oral formats that reduce serving volume without disrupting established prescribing references. | ONS specialists are extending compact ranges with more flavor choice and clearer product naming. | Compact formats can retain repeat use where beverage volume or taste fatigue limits adherence. |
| Abbott launched a new and advanced Ensure Diabetes Care formulation in November 2025. | Clinical nutrition users compare nutrient profiles against condition-specific diet goals before repeat purchase. | Large nutrition groups are refreshing oral formulations for narrower clinical and metabolic use cases. | The formulation work expands technical experience with targeted oral nutrition used under professional supervision. |
| Kate Farms launched its Kids Nutrition line in select Walmart stores in September 2025. | Families and clinicians need complete plant-based nutrition to remain available after medical-channel recommendation. | Clinical nutrition brands are widening retail access without abandoning medically used product routes. | National retail placement can reduce channel gaps between specialist recommendation and repeat home purchase. |
Danone S.A. (Nutricia), Nestlé Health Science, Ajinomoto Co., Inc. (Nualtra), Meiji Co., Ltd., and AYMES Nutrition compete outside the three-row map using specialized oral nutrition and clinical distribution.
Source: Future Market Insights, Eating-Disorder Recovery Nutrition and Clinical Nutrition Market Reports, 2026-2036.
Together the eight profiled companies cover hospital specification, prescription oral nutrition, home supply, retail access, pediatric options, and compact high-nutrition formats used under professional supervision.
Who leads the eating-disorder recovery nutrition market?
No company has a verified public market-share lead for this defined niche. Abbott Laboratories, Danone S.A. (Nutricia), Nestlé Health Science, and Fresenius Kabi have the broadest documented medical-nutrition platforms.
Which suppliers have documented qualification or quality approvals?
Meiji Co., Ltd. documents Consumer Affairs Agency approval for selected Mei Balance products as foods for special dietary uses. Public qualification evidence differs by product and country, so portfolio breadth alone does not establish approval.
Which companies provide complete or compact oral nutrition products?
Abbott Laboratories, Danone S.A. (Nutricia), Nestlé Health Science, Ajinomoto Co., Inc. (Nualtra), AYMES Nutrition, Meiji Co., Ltd., and Kate Farms document finished oral nutrition formats. Their portfolios differ in calorie density, texture, age focus, and channel reach.
Which suppliers serve North America and Europe?
Abbott Laboratories, Danone S.A. (Nutricia), Nestlé Health Science, and Fresenius Kabi operate medical-nutrition businesses in North America and Europe. Kate Farms has greater USA concentration, whereas Nualtra and AYMES maintain stronger UK and Ireland positions.
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| Abbott Laboratories | Global adult-nutrition platform with oral shake formats and broad healthcare distribution. | In May 2026, Abbott launched Ensure Strength Pro in India with 31 nutrients and 30 grams of protein per 100 grams. |
| Danone S.A. (Nutricia) | Global specialized-nutrition group with Fortimel oral nutrition and hospital-to-home distribution. | In February 2025, Nutricia launched Fortimel Plantbased Protein in Spain as a fully plant-based high-protein oral supplement. |
| Nestlé Health Science | Global medical-nutrition platform spanning adult, pediatric, oral, and adjacent enteral formats. | In March 2026, Nestlé launched Compleat Paediatric Oral Blends in select European markets in an on-the-go pouch. |
| Fresenius Kabi | Clinical-nutrition company with complete oral and tube-feeding formats. Tube feeds remain adjacent to this market scope. | In March 2026, Fresenius Kabi launched Fresubin PLANT-BASED Tube Feed in the UK beside its oral plant-based drink. |
| Kate Farms | USA plant-based medical-nutrition company with clinical and expanding retail access. | In November 2025, Kate Farms placed High Protein Nutrition Shake in select Walmart stores and Walmart.com. |
| Ajinomoto Co., Inc. (Nualtra) | UK and Ireland ONS specialist with compact adult formats and a pediatric oral-nutrition extension. | In July 2025, Nualtra documented the launch of its first pediatric product, Altrini Compact Fibre, alongside an ARFID webinar. |
| Meiji Co., Ltd. | Japan-focused high-nutrition platform with compact oral formats for controlled energy and nutrient intake. | In March 2025, Meiji launched the Mei Balance Mini Cup Onion Soup flavor nationwide and refreshed its Corn Soup flavor. |
| AYMES Nutrition | UK oral-nutrition specialist with complete, compact, dessert, and powder formats used under medical supervision. | In January 2026, AYMES introduced two new Actagain Creme flavors as part of its rebrand program. |
Research Methodology
The companies mapped here illustrate market structure rather than an exhaustive ranking. Inclusion requires current, verifiable evidence that a company supplies oral medical nutrition, complete oral nutritional supplements, compact calorie-dense nutrition, or adjacent clinical nutrition that can serve eating-disorder recovery. Evidence comes from regulatory approvals, third-party certifications, company announcements, and public filings. Capabilities are attributed to the stated oral or medical nutrition platform rather than generalised across broader corporate portfolios. Market-share estimates are proprietary FMI assessments for the forecast period.
